These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16532637)

  • 1. [Role of the components of the S-layer in immunogenicity of Bacillus anthracis].
    Mikshis NI; Korsakova AIu; Bolotnikova MF; Novikova LV; Popov IuA
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):29-32. PubMed ID: 16532637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
    Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK
    J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the immune response to the UK human anthrax vaccine.
    Baillie L; Hebdon R; Flick-Smith H; Williamson D
    FEMS Immunol Med Microbiol; 2003 May; 36(1-2):83-6. PubMed ID: 12727370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenicity of protective antigen extracted from asporogenic recombinant strain Bacillus anthracis].
    Mikshis NI; Popova PIu; Kudriavtseva OM; Goncharova AIu; Popov IuA; Kutyrev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):44-8. PubMed ID: 21446166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-layer homology motif is an immunogen and confers protection to mouse model against anthrax.
    Kulshreshtha P; Aggarwal S; Jaiswal H; Bhatnagar R
    Mol Immunol; 2012 Feb; 50(1-2):18-25. PubMed ID: 22178119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a subunit vaccine against Bacillus anthracis.
    Chichester JA; Musiychuk K; de la Rosa P; Horsey A; Stevenson N; Ugulava N; Rabindran S; Palmer GA; Mett V; Yusibov V
    Vaccine; 2007 Apr; 25(16):3111-4. PubMed ID: 17280756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W
    BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.
    Uchida M; Harada T; Enkhtuya J; Kusumoto A; Kobayashi Y; Chiba S; Shyaka A; Kawamoto K
    Biochem Biophys Res Commun; 2012 May; 421(2):323-8. PubMed ID: 22507985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.
    Cowan GJ; Atkins HS; Johnson LK; Titball RW; Mitchell TJ
    Vaccine; 2007 Oct; 25(41):7197-205. PubMed ID: 17765365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.
    Schully KL; Sharma S; Peine KJ; Pesce J; Elberson MA; Fonseca ME; Prouty AM; Bell MG; Borteh H; Gallovic M; Bachelder EM; Keane-Myers A; Ainslie KM
    Pharm Res; 2013 May; 30(5):1349-61. PubMed ID: 23354770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge.
    Köhler SM; Baillie LW; Beyer W
    Vaccine; 2015 Jun; 33(24):2771-7. PubMed ID: 25917676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
    Marcus H; Danieli R; Epstein E; Velan B; Shafferman A; Reuveny S
    Infect Immun; 2004 Jun; 72(6):3471-7. PubMed ID: 15155654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax vaccines.
    Friedlander AM; Welkos SL; Ivins BE
    Curr Top Microbiol Immunol; 2002; 271():33-60. PubMed ID: 12224523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectives.
    Adamo R
    Expert Rev Vaccines; 2014 Jul; 13(7):895-907. PubMed ID: 24867680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.